当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析

亚虹医药-U

(688176)

  

流通市值:53.81亿  总市值:70.54亿
流通股本:4.36亿   总股本:5.71亿

亚虹医药-U(688176)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.70亿元,每股收益-0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益181485.77万元,未分配利润-159082.92万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产217466.04万元,负债35980.28万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入130,237,475.1361,101,125.72201,562,432.59138,951,629.03
营业总成本315,289,508.12152,883,339.26609,000,649.86422,331,119.09
其他经营收益
营业利润-167,498,407.9-85,719,477.84-383,805,943.59-268,659,981.92
利润总额-170,534,193.48-86,391,242.73-386,795,826.88-271,557,522.32
净利润-170,012,214.31-86,341,679.22-386,000,059.67-271,342,070.94
每股收益
其他综合收益824,831.05-52,203.72-5,208,757.06-2,291,721.15
综合收益总额-169,187,383.26-86,393,882.94-391,208,816.73-273,633,792.09
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,853,436,367.241,780,132,063.571,530,945,418.211,598,463,174.92
非流动资产:
非流动资产合计321,224,052.73381,431,167.4692,046,485.58715,379,353.25
资产总计2,174,660,419.972,161,563,230.972,222,991,903.792,313,842,528.17
流动负债:
流动负债合计312,730,467.19221,202,487.62197,059,830.76177,890,199.89
非流动负债:
非流动负债合计47,072,296.7351,104,994.1955,558,274.5356,303,371.38
负债合计359,802,763.92272,307,481.81252,618,105.29234,193,571.27
所有者权益(或股东权益):
归属于母公司股东权益合计1,819,476,153.991,890,799,054.311,969,405,336.092,078,328,413.08
股东权益合计1,814,857,656.051,889,255,749.161,970,373,798.52,079,648,956.9
负债和股东权益合计2,174,660,419.972,161,563,230.972,222,991,903.792,313,842,528.17
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计136,005,902.2761,061,157.83195,899,049.99128,580,141.19
经营活动现金流出小计330,277,080.67171,418,315.44620,849,902.16453,739,827.29
经营活动产生的现金流量净额-194,271,178.4-110,357,157.61-424,950,852.17-325,159,686.1
投资活动产生的现金流量:
投资活动现金流入小计3,333,733,553.91,534,792,114.972,395,262,459.833,401,030,620.39
投资活动现金流出小计3,373,608,447.241,215,228,607.381,598,008,544.962,957,271,644.36
投资活动产生的现金流量净额-39,874,893.34319,563,507.59797,253,914.87443,758,976.03
筹资活动产生的现金流量:
筹资活动现金流入小计167,647,243.7277,290,00066,200,00036,500,000
筹资活动现金流出小计46,701,462.6141,572,485.23143,210,871.59105,856,986.44
筹资活动产生的现金流量净额120,945,781.1135,717,514.77-77,010,871.59-69,356,986.44
汇率变动对现金及现金等价物的影响-308,215.120,225.13-1,954,293.65-232,028.76
现金及现金等价物净增加额-113,508,505.73244,944,089.88293,337,897.4649,010,274.73
期末现金及现金等价物余额507,126,460.38865,579,055.99620,634,966.11376,307,343.38
补充资料:
现金及现金等价物的净增加额-113,508,505.73-293,337,897.46-
最新报告期:2025-08-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
财通证券华挺-0.36-0.100.172025-08-30
西南证券杜向阳,汤泰萌-0.75-0.76-0.712025-08-29
TOP↑